Published April 2021 | Version v1
Journal article

Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

Description

International audience

Additional details

Created:
December 4, 2022
Modified:
November 29, 2023